X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4248) 4248
Publication (457) 457
Book Chapter (45) 45
Book Review (40) 40
Dissertation (15) 15
Conference Proceeding (10) 10
Book / eBook (3) 3
Magazine Article (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3054) 3054
cll (2628) 2628
hematology (2042) 2042
index medicus (1791) 1791
oncology (1781) 1781
male (1562) 1562
female (1513) 1513
middle aged (1419) 1419
aged (1391) 1391
chronic lymphocytic leukemia (1240) 1240
leukemia, lymphocytic, chronic, b-cell - pathology (984) 984
leukemia, lymphocytic, chronic, b-cell - genetics (938) 938
adult (875) 875
leukemia, lymphocytic, chronic, b-cell - drug therapy (760) 760
aged, 80 and over (758) 758
prognosis (727) 727
leukemia (710) 710
cancer (642) 642
b-cll (640) 640
apoptosis (637) 637
survival (617) 617
chronic lymphocytic-leukemia (579) 579
expression (576) 576
leukemia, lymphocytic, chronic, b-cell - immunology (552) 552
leukemia, lymphocytic, chronic, b-cell - metabolism (542) 542
fludarabine (490) 490
rituximab (439) 439
flow cytometry (421) 421
hemic and lymphatic diseases (415) 415
leukemia, lymphocytic, chronic, b-cell - diagnosis (399) 399
mutation (371) 371
therapy (363) 363
disease progression (358) 358
lymphoma (338) 338
leukemia, lymphocytic, chronic, b-cell - mortality (336) 336
treatment outcome (327) 327
diagnosis (324) 324
research (319) 319
leukemia, lymphocytic, chronic, b-cell - therapy (313) 313
chronic lymphatic leukemia (302) 302
care and treatment (301) 301
animals (298) 298
activation (297) 297
cd38 expression (297) 297
antineoplastic agents - therapeutic use (268) 268
genetic aspects (268) 268
disease (267) 267
analysis (265) 265
vidarabine - analogs & derivatives (259) 259
lymphomas (256) 256
antineoplastic combined chemotherapy protocols - therapeutic use (254) 254
b-cells (249) 249
immunophenotyping (246) 246
hematology, oncology and palliative medicine (243) 243
leukemia, lymphocytic, chronic, b-cell - blood (240) 240
cyclophosphamide (238) 238
immunology (237) 237
article (235) 235
cell biology (234) 234
tumor cells, cultured (227) 227
ibrutinib (223) 223
in-vitro (220) 220
apoptosis - drug effects (215) 215
chronic lymphocytic leukaemia (212) 212
chemotherapy (211) 211
pathology (211) 211
immune system diseases (208) 208
gene expression (207) 207
b-lymphocytes - pathology (203) 203
b-lymphocytes - immunology (202) 202
lymphatic leukemia (190) 190
medicine & public health (190) 190
neoplasm staging (187) 187
cll cells (185) 185
mice (184) 184
risk factors (182) 182
cells (181) 181
proteins (174) 174
antineoplastic agents - pharmacology (173) 173
gene (173) 173
immunotherapy (173) 173
medicine, research & experimental (172) 172
alemtuzumab (169) 169
signal transduction (169) 169
cell line, tumor (168) 168
genes (166) 166
chromosome aberrations (165) 165
genomic aberrations (165) 165
health aspects (164) 164
in situ hybridization, fluorescence (164) 164
t-cells (164) 164
survival analysis (163) 163
development and progression (162) 162
b-lymphocytes - metabolism (161) 161
leukemia, lymphocytic, chronic, b-cell - complications (161) 161
patients (161) 161
immunoglobulin heavy chains - genetics (160) 160
phenotype (158) 158
retrospective studies (158) 158
proliferation (152) 152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4211) 4211
French (29) 29
German (20) 20
Russian (12) 12
Polish (7) 7
Japanese (5) 5
Korean (3) 3
Spanish (3) 3
Hungarian (2) 2
Portuguese (2) 2
Chinese (1) 1
Dutch (1) 1
Icelandic (1) 1
Persian (1) 1
Serbian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1873 - 1883
Summary Background Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based... 
Internal Medicine | BENDAMUSTINE | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CLL | CYCLOPHOSPHAMIDE | CHEMOIMMUNOTHERAPY | RITUXIMAB | MONOCLONAL-ANTIBODIES | ELDERLY-PATIENTS | FLUDARABINE | HUMAN CD20 | Age Distribution | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Chlorambucil - adverse effects | Prospective Studies | Chlorambucil - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Aged, 80 and over | Adult | Female | Chlorambucil - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Antineoplastic Agents, Alkylating - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Distribution | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Antineoplastic Agents, Alkylating - adverse effects | Chlorambucil | Medical colleges | Hospitals | Comorbidity | United Kingdom | Product development | India | Medical research | Flow cytometry | Immunoglobulins | Medical imaging | Laboratories | Cytotoxicity | Infections | Ovarian cancer | Bone marrow | Drug dosages | Age | Binding sites | Geriatrics | Neutropenia
Journal Article
Journal Article